Company profile: PointCare
1.1 - Company Overview
Company description
- Provider of cellular analysis methods, inventing and developing methods in the field of cellular analysis.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PointCare
Alpha-Tec Systems
HQ: United States
Website
- Description: Provider of accurate specimen collection, transportation, processing, and quality control solutions for clinical labs, including AFB processing systems (NAC-PAC EA3, UNITARY, RED), fertility and immune testing products (QC-Beads, CitricScreen, FructoScreen, LeucoScreen, ImmunoSpheres, MarScreen), Microbix REDx and PROCEEDx controls, and the OxA oxalic acid decontamination kit for Pseudomonas spp.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alpha-Tec Systems company profile →
Anadys Pharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical therapeutics for chronic hepatitis C, developing ANA598, a direct-acting antiviral (DAA), and resuming clinical development of ANA773.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Anadys Pharmaceuticals company profile →
iosBio
HQ: United Kingdom
Website
- Description: Provider of thermally stable oral vaccine platforms and services, offering vaccine manufacturing, distribution, and delivery. Its OraPro technology uses viral vectors to deliver capsule-based vaccines to the GI tract, enabling mucosal and systemic immunity without cold-chain storage. Products include OraPro and OraPro-Covid-19, an at-home oral vaccine targeting S and N proteins.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full iosBio company profile →
AIM ImmunoTech
HQ: United States
Website
- Description: Provider of immuno-pharmaceutical therapeutics centered on Ampligen, an immuno-modulator evaluated for cancer, immunodeficiency disorders and viral diseases, and approved in Argentina for severe chronic fatigue syndrome. Operates an Early Access Program in the Netherlands for pancreatic cancer, runs Phase 2 and combinational therapy trials in solid tumors, and studies ME/CFS and post-COVID conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AIM ImmunoTech company profile →
Affinium Pharmaceuticals
HQ: United States
Website
- Description: Provider of specialty pharmaceutical research and development focused on novel anti-infective medicines, advancing FASII antibacterial programs as a new antibiotic franchise with potential for multiple products targeting the FASII pathway, supported by a broad base of long-term intellectual property.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Affinium Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PointCare
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PointCare
2.2 - Growth funds investing in similar companies to PointCare
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PointCare
4.2 - Public trading comparable groups for PointCare
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →